← All posts
May 13, 2026 · Tapeline

Stock screener vs stock scanner: the difference matters in 2026.

Everyone uses 'screener' and 'scanner' interchangeably. They're not the same thing — and the difference predicts whether your tool will earn its slot in your daily workflow or get cancelled in three months.

Two of the most common Google queries in active retail trading are "stock screener" and "stock scanner". Most people treat them as synonyms. Most tools position themselves as both. They are not the same thing, and conflating them is how traders end up with $30/mo subscriptions they never open.

The difference, in one sentence: a screener gives you filters; a scanner gives you a verdict. Both can be useful. Only one of them earns daily reuse.

What a screener actually does

A screener is a multi-field filter. You pick fields (price, P/E, RSI, market cap, sector, 20DMA distance, IV rank, insider ownership …) and set thresholds. The screener returns the rows that match. That's it. The output is a list of tickers; the synthesis — what each row actually means — is on you.

Canonical example: Finviz. You can build a screen for "small-cap tech, P/E under 15, RSI below 30, above the 200DMA, insider buying last 6 months" and get a list back. The tool has done a database query for you. It hasn't formed an opinion.

This is genuinely useful for a particular workflow: when you already know what you're looking for and you need a fast database query against the whole market. Anyone who's run a value-investing checklist or scanned for option-IV outliers has used screeners well.

It is not what most retail traders actually need most mornings. Most mornings, what a retail trader wants is "what changed overnight that I should care about." Screening doesn't answer that — you have to know in advance what filter to set.

What a scanner actually does

A scanner is opinionated. It runs a model — anything from a simple weighted score to a deep-learning ensemble — and produces a ranked list with a verdict per row. The output is a recommendation shape: this is the top of the distribution today, here's why, here's how the signal label maps to the underlying score.

The point of a scanner isn't the filters. It's the synthesis. The tool has decided what matters, weighted it, and surfaced the conclusion. You can disagree with the weighting — but you can't avoid seeing the conclusion.

This matters because the binding constraint on most retail traders isn't data access. It's attention. The market has 2,500 liquid US tickers; nobody reads all of them. A screener helps you find what you're looking for. A scanner helps you find what you didn't know to look for.

Why the distinction predicts six-month retention

If you've subscribed to multiple finance tools, you've seen this pattern: a screener gets daily use for the first week, then weekly use, then monthly, then never. A good scanner gets daily use indefinitely. The difference isn't the data behind them — most tools use overlapping data feeds. The difference is the cognitive load per session.

Screeners require you to bring the question. Scanners hand you the question already formed. When you have 10 minutes before market open and three personal-life things on your mind, the cognitive cost of "construct a useful screen this morning" outweighs the cost of opening the app at all. So you don't open it.

This isn't a problem with the user. It's a structural property of the tool category. The scanner format has lower activation energy and therefore higher retention.

The "scanner that gives you a screener" trap

Many tools position as both. TradingView calls itself a scanner; the actual product is a charting platform with filter overlays. Trade Ideas has Holly AI (scanner-shaped) AND a flexible filter builder (screener-shaped). The marketing fudges the line.

That's fine as positioning. It does mean you need to look at what the tool actually defaults to when you open it. If the default view is a blank filter panel waiting for you to build something, you have a screener. If the default view is a ranked list with a verdict per row, you have a scanner.

By that test, Tipranks, Zacks, and WallStreetZen are scanners (they default to a ranking with a per-row verdict — a Smart Score, a Zacks Rank, a Zen Rating). Finviz, in spite of its premium tier, is a screener (the default is a filterable table where you bring the criteria). Most "AI stock scanners" in 2025/26 are also scanners by this test — though many hide the formula behind that verdict, which is its own problem (the formula is public goes deep on that).

Which one Tapeline is

Tapeline is a scanner. The default view at /app/scanner is a ranked list of every liquid US ticker with a 0–100 composite score and a plain-English sentence per row. The six-factor formula is public; the scorecard back-checks every top-10 daily pick against the next session vs SPY.

You can also filter — by sector, by signal label, by minimum score, etc. — and the score breakdown lets you reproduce screener- shaped queries when you want to. But the default is the verdict. That's the design choice, and it's deliberate. Five minutes a morning, ranked list, one sentence per row. Click the names you care about; ignore the rest.

How to decide which you need

Pick the screener if:

  • You already have a defined strategy (value, momentum, options-IV outliers, post-earnings drift) and you need to surface candidates that fit it.
  • You enjoy designing filters and tuning them over time.
  • You're willing to do the synthesis work yourself.

Pick the scanner if:

  • You want a daily ranked starting point you didn't have to build.
  • You want the tool to do the synthesis work and you'll bring the discretion.
  • You want accountability — a scanner with a public scorecard is the only way to tell whether the model is actually working over time.

Both can be useful. Don't pay for two if you only use one. Don't subscribe to either if you can't tell which kind you have.

If you're not sure where to start, the Tapeline vs Finviz comparison goes into the screener-vs-scanner question head-to-head with a real $24.99/mo entry tier. Both products do useful work; they don't do the same work.

See it live.

14-day Premium trial. No credit card. The scoring formula above runs on every US ticker every minute.